Correlation Between Akili and Aclarion
Can any of the company-specific risk be diversified away by investing in both Akili and Aclarion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akili and Aclarion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akili Inc and Aclarion, you can compare the effects of market volatilities on Akili and Aclarion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akili with a short position of Aclarion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akili and Aclarion.
Diversification Opportunities for Akili and Aclarion
Pay attention - limited upside
The 3 months correlation between Akili and Aclarion is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Akili Inc and Aclarion in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aclarion and Akili is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akili Inc are associated (or correlated) with Aclarion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aclarion has no effect on the direction of Akili i.e., Akili and Aclarion go up and down completely randomly.
Pair Corralation between Akili and Aclarion
If you would invest (100.00) in Akili Inc on November 27, 2024 and sell it today you would earn a total of 100.00 from holding Akili Inc or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Akili Inc vs. Aclarion
Performance |
Timeline |
Akili Inc |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Aclarion |
Akili and Aclarion Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Akili and Aclarion
The main advantage of trading using opposite Akili and Aclarion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akili position performs unexpectedly, Aclarion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aclarion will offset losses from the drop in Aclarion's long position.Akili vs. EUDA Health Holdings | ||
Akili vs. FOXO Technologies | ||
Akili vs. Aclarion | ||
Akili vs. National Research Corp |
Aclarion vs. EUDA Health Holdings | ||
Aclarion vs. FOXO Technologies | ||
Aclarion vs. Healthcare Triangle | ||
Aclarion vs. Mangoceuticals, Common Stock |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Fundamental Analysis View fundamental data based on most recent published financial statements |